Pharmacology
Conference Coverage
New trial suggests CV benefit with EPA: RESPECT-EPA
The open-label trial could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose...
Conference Coverage
Study sheds new light on RAS inhibitors’ role for advanced CKD
“The results of this trial will inform future clinical practice worldwide and guideline recommendations.”
News
New CDC guidance on prescribing opioids for pain
New evidence has emerged regarding the benefits and risks of prescription opioids for acute and chronic pain.
News
Single dose of psilocybin for major depression tied to short-term remission
“The findings are both intriguing and sobering.”
News
FDA rejects bulevirtide for hepatitis D
The FDA cited concerns over the production and delivery of bulevirtide, an investigational, first-in-class hepatitis delta virus entry-inhibitor...
News
Best anticoagulant for minimizing bleeding risk identified
“Apixaban stood out as having lower risk of gastrointestinal bleeding.”
Conference Coverage
Dupilumab improves eosinophilic esophagitis up to 24 weeks
The drug received FDA approval for EoE treatment earlier in 2022.
Conference Coverage
RBX2660 shows promise in breaking the cycle of recurrent C. difficile
“Even when you expand the patient population to make it more generalizable, we’re still seeing both a high cure rate and a high success rate.”
News
$38,398 for a single shot of a very old cancer drug
The first issue is unrelenting price increases on old drugs that have remained branded as manufacturers find ways to extend patents for decades...
News
Study affirms better breast cancer outcomes when chemo comes first
Survival is better when high-risk breast cancer patients receive chemo first, followed by abemaciclib and estrogen therapy.